INTRODUCTION: Antiaggregant and anticoagulant therapy has possible sever secondary effects, being the most serious @entity510 . OBJECTIVES: Compare morbi-mortality between surgical and medical treatments in anticoagulated and/or antiaggregated @entity1 with any kind of @entity510 . Also risk factors and main indications of those treatments are studied. @entity1 AND METHODS: Descriptive and retrospective study including 105 @entity1 admitted in our Critical Care Unit, with @entity510 , under anticoagulant or antiaggregant treatment. We study the type of @entity548 (subarachnoid, epidural, subdural and intraparenchimal @entity548 ) and the relation between morbi-mortality and treatment applicated using relative risk like analytic tool. RESULTS: Major @entity548 risk appears after the six first months from the beginning of the treatment. Thirty-four @entity1 died with a relative risk of 1.55 in the surgical @entity1 from the medical treatment @entity1 . Relative risk between anticoagulated patients and antiaggregated ones was 1.16. Serious consequences happened on eight of the 49 @entity1 under surgical treatment, and on 13 of the 52 @entity1 under medical treatment. CONCLUSIONS: Surgical treatment has more morbi-mortality. Oral anticoagulation has only a little more relative risk than treatment with antiaggregants. Both groups had serious consequences.

[Morbi-mortality of medical and surgical treatments in the XXXX like complication of therapy with drugs that modifies normal coagulation].

@entity1 :: ('9606', 'Species') :: ['PATIENTS', 'patients'] @entity548 :: ('MESH:D006470', 'Disease') :: ['bleeding'] @entity510 :: ('MESH:D013345', 'Disease') :: ['intracranial bleeding']
@entity510 :: (MESH:D013345,Disease) :: ['intracranial bleeding']
